Association between shortened maternal and fetal telomere length and abnormal fetal development
PLOS One · 2025
DOI: 10.1371/journal.pone.0327724 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Océane Coudrieu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cytogénétique Médicale, CHU Estaing; Université Clermont Auvergne, UFR de Médecine et professions paramédicales, Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Fetal Development, Fetus, Telomere, Telomere Shortening. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A number of intrinsic, maternal and environmental factors have been linked to the risk of fetal developmental anomalies. In a previous study, we showed that telomere length (TL) was notably reduced in amniotic fluid when the fetus exhibited a developmental anomaly. In this new study, we measured the fetal and maternal TL for 75 evolutive pregnancies with congenital malformation. We also measured the TL of 50 pregnant women without fetal anomalies and 50 non-pregnant control women who had at least one child with normal development. In fetal samples, telomeres were significantly shortened in cases with congenital anomalies compared to controls (n = 93) (P < 0.0001). Interestingly, age-adjusted maternal TL was also significantly reduced in these cases (P < 0.01). Receiver operating characteristic (ROC) analysis showed that maternal TL, at the optimal cut-off value, identified cases of congenital anomalies with 92% specificity and 73% sensitivity. In addition, fetal and maternal TL were correlated, with 15% to 38% of the variance in fetal TL attributable to maternal TL. Telomere shortening can lead to increased sensitivity to various maternal exposure factors and may contribute to compromised organogenesis, possibly due to inadequate cell proliferation or genomic instability. Measuring maternal TL during the periconceptional period could serve as a useful predictive biomarker for assessing the risk of fetal developmental anomalies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cytogénétique Médicale, CHU Estaing; Université Clermont Auvergne, UFR de Médecine et professions paramédicales, Clermont-Ferrand, France.
- CNRS, Inserm, iGReD, Université Clermont Auvergne, Clermont-Ferrand, France.
- Unité de Médecine Fœtale, CHU Clermont-Ferrand, CHU Estaing, Clermont-Ferrand, France.
- EA7453 CHELTER, Clonal Heterogeneity, Leukemic environment, Therapy resistance of chronic leukemias, Université Clermont Auvergne, Clermont-Ferrand, France.
- INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques, Université Clermont Auvergne, Clermont-Ferrand, France.
ORCID-Profile: Carole Goumy
Zitieren
APA
Coudrieu, O., Ouedraogo, Z. G., Gallot, D., Delabaere, A., Veronese, L., Eymard-Pierre, E., Tchirkov, A., & Goumy, C. (2025). Association between shortened maternal and fetal telomere length and abnormal fetal development. PLOS One. https://doi.org/10.1371/journal.pone.0327724
Vancouver
Coudrieu O, Ouedraogo ZG, Gallot D, Delabaere A, Veronese L, Eymard-Pierre E, et al. Association between shortened maternal and fetal telomere length and abnormal fetal development. PLOS One. 2025. doi:10.1371/journal.pone.0327724
BibTeX
@article{Coudrieu2025,
author = {Coudrieu, Océane and Ouedraogo, Zangbéwendé Guy and Gallot, Denis and Delabaere, Amélie and Veronese, Lauren and Eymard-Pierre, Eleonore and Tchirkov, Andrei and Goumy, Carole},
title = {Association between shortened maternal and fetal telomere length and abnormal fetal development},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0327724}
}
EUVIMED